Procedure code and Description
92002 Ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; intermediate, new patient
92004 Ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; comprehensive, new patient, one or more visits
92012 Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient
Refraction:
CPT 92015 describes refraction and any necessary prescription of lenses. Refraction is not separately reimbursed as part of a routine eye exam or as part of a medical examination and evaluation with treatment/diagnostic program.
Payment and Coding Policy Enforcement:
The enforcement of the directives in this policy does not involve medical necessity review. Limitations on recovery for incorrectly coded services may not apply as incorrect coding may be viewed as fraudulent reporting
Procedure codes 65771, 92015, 92310, 92340-92342, 92370, 92390, 92391, are listed by Medicare with a status code “N”. These services are non-covered by statute. Beneficiaries may be billed for these services. The beneficiary should be notified these services are non-covered and informed of the cost the physician will charge for the service. These services do not need to be billed to Medicare, unless the beneficiary requests they be billed for denial. In this situation the services should be billed in the routine manner and with a GY modifier.
An evaluation of the eyes not related to a medical or surgical condition; including but not limited to refractive services. CPT Codes: 92002, 92004, 92012, 92014, 92015, 99172, and 99173 Beneficiary Coverage TRICARE Prime TRICARE Extra TRICARE Standard
Guideline from Medicaid
For participants under the age of 21, providers may bill a refraction (CPT 92015) without the exam. Determination of refractive state includes specification of lens type, lens power, axis, prism, absorptive factor, impact resistance, interpupillary distance and other necessary factors.
Special Ophthalmological Services
Special ophthalmological services are special evaluations of part of the visual system, which go beyond the services included under general ophthalmological services or in which special treatment is given. Interpretation and report by the provider is an integral part of special ophthalmological services.
The following procedures do not need prior authorization.
• Slit lamp examination
• Keratometry
• Routine ophthalmoscopy
• Retinoscopy
• Refractometry
• Tonometry
• Biomicroscopy
• Examination with cycloplegia or mydriasis
• Motor evaluation
Medical Examinations and Evaluations with Initiation/Continuation of Diagnostic and Treatment Program:
CPT codes 92002-92014 are for medical examination and evaluation with initiation or continuation of a diagnostic and treatment program. The intermediate services (92002, 92012) describe an evaluation of a new or existing condition complicated with a new diagnostic or management problem with initiation of a diagnostic and treatment program. They include the provision of history, general medical observation,external ocular and adnexal examination and other diagnostic procedures as indicated, including mydriasis for ophthalmoscopy. The comprehensive services include a general examination of the complete visual system and always include initiation of diagnostic and treatment programs.
These services are valued in relationship to E/M services, though past Medicare fee schedule work relative value unit cross walks from ophthalmological services to E/M no longer exist. Nonetheless, the valuations provide some understanding of the type of medical decision-making (MDM) that might be expected. 92002 is closest to 99202 (low or moderate MDM) and 92004 is between 99203 and 99204 (moderate to high MDM). Code 92012 is closest to 99213 (low to moderate MDM) and 92014 is closest to 99214 (moderate to high MDM).
These services require that the patient needs and receives care for a condition other than refractive error. They are not for screening/preventive eye examinations, prescription of lenses or monitoring of contact lenses for refractive error correction (i.e. other than bandage lenses or keratoconus lens therapy). There must be initiation of treatment or a diagnostic plan for a comprehensive service to be reported. An intermediate service requires initiation or continuation of a diagnostic or treatment plan. Follow-up of a condition that does not require diagnosis or treatment does not constitute a service reported with 92002-92014. For example, care of a patient who has a history of self limited allergic conjunctivitis controlled by OTC antihistamines who is being seen primarily for a preventive exam should not be reported using 92002-92014.
A patient who has an early or incidentally identified cataract and is not being seen for visual disturbance related to the cataract, but is being seen primarily for refraction or screening, is not receiving a service reported with 92002-92014.
Medical examinations and evaluations with initiation/continuation of treatment or diagnostic programs for the treatment of disease are typically covered services without limitation. Ophthalmologic screening/preventive exams and exams for refractive error, commonly referred to as “Routine Eye Exams”, are typically limited benefit services, e.g. one every 24 months. Glaucoma screening for high risk Medicare beneficiaries is covered once every 12 months and should be reported with HCPCSII code.
Reporting screening, preventive or refractive error services with codes 92002-92014 is misrepresentation of the service, potentially to manipulate eligibility for benefits and is fraud. If the member has no coverage for a routine eye exam or lens services, it is appropriate to inform the member of their financial responsibility. Do not provide the member with a receipt for 92002-92014 if providing a non-covered preventive/screening Routine Eye Exam service as the member may seek clarification from BCBSRI and these services are typically covered.
Routine Ophthalmological Evaluation, Including Refraction: HCPCS Codes S0620 and S0621 are used for these services for the new and established patient, respectively. If during the course of an evaluation it is necessary to initiate a treatment or diagnostic program, the appropriate CPT code (92002-92014) may be reported instead. An insignificant or trivial problem/abnormality that is encountered in the process of performing the routine examination and which does not require significant additional work would not warrant use of the CPT code.
- Laser interferometry.
- Potential acuity meter.
- Keratometry.
- Exophthalmometry.
- Transillumination.
- Corneal sensation.
- Tear film adequacy.
- Schirmer’s test.
- Slit lamp.
- General medical observation.
- The prescription of medication, lenses and other therapy.
- Arranging for special ophthalmological, diagnostic or treatment services.
- Consultation.
- Laboratory procedures.
- Radiological services as may be indicated.
- Safe and effective.
- Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
- Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
- Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
- Furnished in a setting appropriate to the patient’s medical needs and condition.
- Ordered and furnished by qualified personnel.
- One that meets, but does not exceed, the patient’s medical need.
- At least as beneficial as an existing and available medically appropriate alternative.
Note:
|
Providers are reminded to refer to the long descriptors of the
|
92002©
|
Eye exam, new patient
|
92004©
|
Eye exam, new patient
|
92012©
|
Eye exam established pat
|
92014©
|
Eye exam & treatment
|
Medicaid coverage on ophthalmologists CPT codes
Medical services provided by ophthalmologists or optometrists are limited to codes 92002, 92004, 92012, 92014, 92020, 92083, 92135, 65210, 65220,65222, 67820, 68761, 68801, 95930, 99201- 99205, 99211-99215.
When a service may be considered medically necessary Routine eye exams (CPT 92002-92014) may be considered medical necessary under the medical benefit only when a disease condition of the eye is found or reasonably suspected. See attachment I for a list of eligible diagnoses.
A screening test for defective vision in conjunction with a preventive medicine evaluation and management service when done in accordance with current American Academy of Pediatrics, American Academy of Family Practice, and/or Bright Futures guidelines by a physician, physician assistant, or advanced practice nurse clinician.
Visual examination without refraction (CPT 92002 – 92014) may be considered medically necessary when a disease state of the eye or known to affect the eye is present or reasonably suspected (see attachment I) or when an individual is undergoing long term treatment (greater than 30 days) with a high risk medication.
When a service is considered not medically necessary Non-computer-assisted corneal topography is considered part of the evaluation/and management services of general ophthalmological services (CPT codes 92002–92014) and reimbursement for Plan contracted providers is set accordingly. Separate reimbursement is not appropriate for this procedure.
CPT 92014 – Ophthalmological services: medical examination and evaluation, with initiation or continuation ofdiagnostic and treatment program; comprehensive, established patient, 1 or more visits
.
ICD-9-CM Codes That Support Medical Necessity
017.00–017.06
|
Tuberculosis of skin and subcutaneous cellular tissue
|
017.10–017.16
|
Erythema nodosum with hyperactivity reaction in tuberculosis
|
017.20–017.26
|
Tuberculosis of peripherial lymph nodes
|
017.30–017.36
|
Tuberculosis of eye unspecified examination
|
017.40–017.46
|
Tuberculosis of ear
|
017.50–017.56
|
Tuberculosis of thyroid gland
|
017.60–017.66
|
Tuberculosis of adrenal glands
|
017.70–017.76
|
Tuberculosis of spleen
|
017.80–017.86
|
Tuberculosis of esophagus
|
017.90–017.96
|
Tuberculosis of other specified organs
|
021.3
|
Oculoglandular tularemia
|
023.8–023.9
|
Brucellosis
|
030.0–030.3
|
Leprosy
|
030.8–030.9
|
Leprosy
|
036.81
|
Meningococcal optic neuritis
|
036.9
|
Meningococcal infection unspecified
|
037
|
Tetanus
|
038.0
|
Streptococcal septicemia
|
038.10–038.12
|
Staphylococcal septicemia
|
038.19
|
Other staphylococcal septicemia
|
038.2–038.3
|
Septicemia
|
038.40–038.44
|
Septicemia due to gram-negative organisms
|
038.49
|
Other septicemia due to gram-negative organisms
|
038.8–038.9
|
Septicemia
|
039.3
|
Cervicofacial actinomycotic infection
|
039.8–039.9
|
Actinomycotic infections
|
040.0–040.3
|
Gas gangrene
|
040.81–040.82
|
Other specified bacterial diseases
|
040.89
|
Other specified bacterial diseases
|
041.00–041.05
|
Streptococcus
|
041.09
|
Other streptococcus
|
041.10–041.11
|
Staphylococcus
|
041.19
|
Other staphylococcus
|
041.2–041.7
|
Bacterial infection in conditions classified elsewhere and of unspecified site
|
041.81–041.86
|
Other specified bacterial infections
|
041.89
|
Other specified bacteria
|
041.9
|
Bacterial infection unspecified
|
042
|
Human immunodeficiency virus (hiv) disease
|
045.00–045.03
|
Acute paralytic poliomyelitis specified as bulbar
|
045.10–045.13
|
Acute poliomyelitis with other paralysis
|
045.20–045.23
|
Acute nonparalytic poliomyelitis
|
045.90–045.93
|
Unspecified acute poliomyelitis
|
046.0
|
Kuru
|
046.19
|
Other and unspecified Creutzfeldt-Jakob disease
|
046.2-046.3
|
Subacute sclerosing panencephalitis
|
046.79
|
Other and unspecified prion disease of central nervous system
|
046.8–046.9
|
Slow virus infection of central nervous system
|
047.0–047.1
|
Meningitis due to enterovirus
|
047.8–047.9
|
Meningitis due to enterovirus
|
048
|
Other enterovirus diseases of central nervous system
|
049.0–049.1
|
Other non-arthropod-borne viral diseases of central nervous system
|
049.8–049.9
|
Other non-arthropod-borne viral diseases of central nervous system
|
053.10–053.13
|
Herpes zoster with meningitis
|
053.19
|
Herpes zoster with other nervous system complications
|
053.20–053.22
|
Herpes zoster dermatitis of eyelid – herpes zoster iridocyclitis
|
053.29
|
Herpes zoster with other ophthalmic complications
|
053.8–053.9
|
Herpes zoster
|
054.2–054.3
|
Herpes simplex
|
054.40–054.44
|
Herpes simplex with unspecified ophthalmic complication – herpes simplex iridocyclitis
|
054.49
|
Herpes simplex with other ophthalmic complications
|
054.5–054.6
|
Herpes simplex
|
054.71–054.73
|
Herpes simplex with other specified complications
|
054.79
|
Herpes simplex with other specified complications
|
054.8–054.9
|
Herpes simplex
|
055.71
|
Measles keratoconjunctivitis
|
055.8
|
Measles with unspecified complication
|
076.0–076.1
|
Trachoma initial stage – trachoma active stage
|
076.9
|
Trachoma unspecified
|
077.0–077.4
|
Inclusion conjunctivitis – epidemic hemorrhagic conjunctivitis
|
077.8
|
Other viral conjunctivitis
|
077.98–077.99
|
Other diseases of conjunctiva due to viruses and chlamydiae
|
078.0
|
Molluscum contagiosum
|
078.3
|
Cat-scratch disease
|
078.5
|
Cytomegaloviral disease
|
078.89
|
Other specified diseases due to viruses
|
079.0–079.4
|
Viral and chlamydial infection in conditions classified elsewhere and of unspecified site
|
079.50–079.53
|
Retrovirus unspecified – human immunodeficiency virus type 2 [hiv-2]
|
079.59
|
Other specified retrovirus
|
079.82
|
Sars-associated coronavirus infection
|
080
|
Louse-borne (epidemic) typhus
|
081.0–081.2
|
Other typhus
|
081.9
|
Typhus unspecified
|
082.0–082.3
|
Tick-borne rickettsioses
|
082.40–082.41
|
Ehrlichiosis
|
091.50–091.52
|
Syphilitic uveitis unspecified – syphilitic iridocyclitis (secondary)
|
094.0–094.1
|
Tabes dorsalis – general paresis
|
094.3
|
Asymptomatic neurosyphilis
|
094.81–094.87
|
Syphilitic encephalitis – syphilitic ruptured cerebral aneurysm
|
095.0
|
Syphilitic episcleritis
|
098.40–098.43
|
Gonococcal conjunctivitis (neonatorum) – gonococcal keratitis
|
098.49
|
Other gonococcal infection of eye
|
099.3
|
Reiter’s disease
|
099.41
|
Other nongonococcal urethritis chlamydia trachomatis
|
115.02
|
Histoplasma capsulatum retinitis
|
115.09
|
Infection by histoplasma capsulatum with other manifestation
|
115.12
|
Histoplasma duboisii retinitis
|
115.19
|
Infection by histoplasma duboisii with other manifestation
|
115.92
|
Histoplasmosis retinitis unspecified
|
115.99
|
Histoplasmosis unspecified with other manifestation
|
125.2
|
Loiasis
|
130.0–130.5
|
Meningoencephalitis due to toxoplasmosis – hepatitis due to toxoplasmosis
|
135
|
Sarcoidosis
|
136.1
|
Behcet’s syndrome
|
171.0
|
Malignant neoplasm of connective and other soft tissue of head face and neck
|
172.1
|
Malignant melanoma of skin of eyelid including canthus
|
173.1
|
Other malignant neoplasm of skin of eyelid including canthus
|
190.0–190.9
|
Malignant neoplasm of eyeball except conjunctiva cornea retina and choroid
|
191.1–191.9
|
Malignant neoplasm of brain
|
192.0–192.1
|
Malignant neoplasm of other and unspecified parts of nervous system
|
192.3
|
Malignant neoplasm of spinal meninges
|
192.8–192.9
|
Malignant neoplasm of other and unspecified sites of nervous system
|
194.3
|
Malignant neoplasm of pituitary gland and craniopharyngeal duct
|
198.3–198.4
|
Secondary malignant neoplasm of other specified sites
|
216.1
|
Benign neoplasm of eyelid including canthus
|
224.0–224.9
|
Benign neoplasm of eye
|
225.0–225.4
|
Benign neoplasm of brain – benign neoplasm of spinal meninges
|
225.8–225.9
|
Benign neoplasm of brain and other parts of nervous system
|
228.03
|
Hemangioma of retina
|
232.1
|
Carcinoma in situ of eyelid including canthus
|
234.0
|
Carcinoma in situ of eye
|
237.0
|
Neoplasm of uncertain behavior of pituitary gland and craniopharyngeal duct
|
241.9
|
Unspecified nontoxic nodular goiter
|
242.00–242.01
|
Toxic diffuse goiter
|
242.10–242.11
|
Toxic uninodular goiter
|
242.20–242.21
|
Toxic multinodular goiter
|
242.30–242.31
|
Toxic nodular goiter unspecified
|
242.40–242.41
|
Thyrotoxicosis from ectopic thyroid nodule
|
242.80–242.81
|
Thyrotoxicosis of other specified origin
|
242.90–242.91
|
Thyrotoxicosis without mention of goiter or other cause
|
244.9
|
Unspecified acquired hypothyroidism
|
246.8–246.9
|
Other disorders of thyroid
|
250.00–250.03
|
Diabetes mellitus without mention of complication
|
250.10–250.13
|
Diabetes with ketoacidosis
|
250.20–250.23
|
Diabetes with hyperosmolarity
|
250.30–250.33
|
Diabetes with other coma
|
250.40–250.43
|
Diabetes with renal manifestations
|
250.50–250.53
|
Diabetes with ophthalmic manifestations
|
250.60–250.63
|
Diabetes with neurological manifestations
|
250.70–250.73
|
Diabetes with peripheral circulatory disorders
|
250.80–250.83
|
Diabetes with other specified manifestations
|
250.90–250.93
|
Diabetes with unspecified complication
|
264.0–264.9
|
Vitamin a deficiency with conjunctival xerosis – unspecified vitamin a deficiency
|
282.60–282.64
|
Sickle-cell disease
|
282.68–282.69
|
Sickle-cell disease
|
300.11
|
Conversion disorder
|
333.81
|
Blepharospasm
|
339.89
|
Other headache syndromes
|
340
|
Multiple sclerosis
|
341.0
|
Neuromyelitis optica
|
346.00–346.03
|
Classical migraine
|
346.10–346.13
|
Common migraine
|
346.20–346.23
|
Variants of migraine
|
346.30-346.33
|
Hemiplegic migraine, without mention of intractable migraine without mention of status migrainosus
|
346.40-346.43
|
Menstrual migraine, without mention of intractable migraine without mention of status migrainosus
|
346.50-346.53
|
Persistent migraine aura without cerebral infarction, without mention of intractable migraine without mention of status migrainosus
|
346.60-346.63
|
Persistent migraine aura with cerebral infarction, without mention of intractable migraine without mention of status migrainosus
|
346.70-346.73
|
Chronic migraine without aura, without mention of intractable migraine without mention of status migrainosus
|
346.80–346.83
|
Other forms of migraine
|
346.90–346.92
|
Migraine unspecified
|
348.2
|
Benign intracranial hypertension
|
350.1
|
Trigeminal neuralgia
|
351.0–351.1
|
Facial nerve disorders
|
351.8–351.9
|
Other facial nerve disorders
|
352.6
|
Multiple cranial nerve palsies
|
357.2
|
Polyneuropathy in diabetes
|
360.00–360.04
|
Purulent endophthalmitis
|
360.11–360.14
|
Other endophthalmitis
|
360.19
|
Other endophthalmitis
|
360.20–360.21
|
Degenerative disorders of globe
|
360.23–360.24
|
Degenerative disorders of globe
|
360.29
|
Other degenerative disorders of globe
|
360.30–360.34
|
Hypotony of eye
|
360.40–360.44
|
Degenerated conditions of globe
|
360.50–360.55
|
Retained (old) intraocular foreign body, magnetic
|
360.59
|
Intraocular foreign body magnetic in other or multiple sites
|
360.60–360.65
|
Retained (old) intraocular foreign body, nonmagnetic
|
360.69
|
Intraocular foreign body in other or multiple sites
|
360.81
|
Luxation of globe
|
360.89
|
Other disorders of globe
|
360.9
|
Unspecified disorder of globe
|
361.00–361.07
|
Retinal detachment with retinal defect
|
361.10–361.14
|
Retinoschisis and retinal cysts
|
361.19
|
Other retinoschisis and retinal cysts
|
361.2
|
Serous retinal detach
|
361.30–361.33
|
Retinal defect without detachment
|
361.81
|
Traction detach of retina
|
361.89
|
Other forms of retinal detach
|
361.9
|
Unspecified retinal detach
|
362.01–362.07
|
Diabetic retinopathy
|
362.10–362.18
|
Other background retinopathy and retinal vascular changes
|
362.20-362.27
|
Retinopathy of prematurity, unspecified
|
362.29
|
Other nondiabetic proliferative retinopathy
|
362.30–362.37
|
Retinal vascular occlusion
|
362.40–362.43
|
Separation of retinal layers
|
362.50–362.57
|
Degeneration of macula and posterior pole
|
362.60–362.66
|
Peripheral retinal degenerations
|
362.70–362.77
|
Hereditary retinal dystrophies
|
362.81–362.85
|
Other retinal disorders
|
362.89
|
Other retinal disorders
|
362.9
|
Unspecified retinal disorder
|
363.00–363.01
|
Focal chorioretinitis and focal retinochoroiditis
|
363.03–363.08
|
Focal chorioretinitis and focal retinochoroiditis
|
363.10–363.15
|
Disseminated chorioretinitis and disseminated retinochoroiditis
|
363.20–363.22
|
Other and unspecified forms of chorioretinitis and retinochoroiditis
|
363.30–363.35
|
Chorioretinal scars
|
363.40–363.43
|
Choroidal degenerations
|
363.50–363.57
|
Hereditary choroidal dystrophies
|
363.61–363.63
|
Choroidal hemorrhage and rupture
|
363.70–363.72
|
Choroidal detachment
|
363.8–363.9
|
Other disorders of choroid
|
364.00–364.05
|
Acute and subacute iridocyclitis
|
364.10–364.11
|
Chronic iridocyclitis
|
364.21–364.24
|
Certain types of iridocyclitis
|
364.3
|
Unspecified iridocyclitis
|
364.41–364.42
|
Vascular disorders of iris and ciliary body
|
364.51–364.57
|
Degenerative changes of iris and ciliary body
|
364.59
|
Other iris atrophy
|
364.60–364.64
|
Cysts of iris, ciliary body and anterior chamber
|
364.70–364.77
|
Adhesions and disruptions of iris and ciliary body
|
364.81–364.82
|
Floppy iris syndrome
|
364.89
|
Other disorders of iris and ciliary body
|
364.9
|
Unspecified disorder of iris and ciliary body
|
365.00–365.04
|
Borderline glaucoma
|
365.10–365.15
|
Open-angle glaucoma
|
365.20–365.24
|
Primary angle-closure glaucoma
|
365.31–365.32
|
Corticosteroid-induced glaucoma
|
365.41–365.44
|
Glaucoma associated with congenital abnormalities, dystrophies and systemic syndromes
|
365.51–365.52
|
Glaucoma associated disorders of the lens
|
365.59
|
Glaucoma associated with other lens disorders
|
365.60–365.65
|
Glaucoma associated with ocular disorders
|
365.81–365.83
|
Other specified forms of glaucoma
|
365.89
|
Other specified glaucoma
|
365.9
|
Unspecified glaucoma
|
366.00–366.04
|
Infantile, juvenile and presenile cataract
|
366.09
|
Other and combined forms of nonsenile cataract
|
366.10–366.19
|
Senile cataract
|
366.20–366.23
|
Traumatic cataract
|
366.30–366.34
|
Cataract secondary to ocular disorders
|
366.41–366.46
|
Cataract associated with other disorders
|
366.50–366.53
|
After-cataract
|
366.8–366.9
|
Other cataract
|
368.00–368.03
|
Amblyopia ex anopsia
|
368.10–368.16
|
Subjective visual disturbances
|
368.2
|
Diplopia
|
368.30–368.34
|
Other disorders of binocular vision
|
368.40–368.47
|
Visual field defects
|
368.51–368.55
|
Color vision deficiencies
|
368.59
|
Other color vision deficiencies
|
368.60–368.63
|
Night blindness
|
368.69
|
Other night blindness
|
368.8–368.9
|
Other specified visual disturbances
|
369.3–369.4
|
Blindness and low vision
|
369.60
|
Blindness one eye not otherwise specified
|
369.8–369.9
|
Unqualified visual loss one eye
|
370.01–370.07
|
Corneal ulcer
|
370.20–370.24
|
Superficial keratitis without conjunctivitis
|
370.31–370.35
|
Certain types of keratoconjunctivitis
|
370.40
|
Keratoconjunctivitis unspecified
|
370.44
|
Keratitis or keratoconjunctivitis in exanthema
|
370.49
|
Other keratoconjunctivitis unspecified
|
370.50
|
Interstitial keratitis unspecified
|
370.52
|
Diffuse interstitial keratitis
|
370.54–370.55
|
Interstitial and deep keratitis
|
370.59
|
Other interstitial and deep keratitis
|
370.60–370.64
|
Corneal neovascularization
|
370.8–370.9
|
Other keratitis
|
371.00–371.05
|
Corneal scars and opacities
|
371.10–371.16
|
Corneal pigmentations and deposits
|
371.20–371.24
|
Corneal edema
|
371.30–371.32
|
Changes of corneal membranes
|
371.40–371.46
|
Corneal degenerations
|
371.48–371.49
|
Corneal degenerations
|
371.50–371.58
|
Hereditary corneal dystrophies
|
371.60–371.62
|
Keratoconus
|
371.71–371.73
|
Other corneal deformities
|
371.81–371.82
|
Other corneal disorders
|
371.89
|
Other corneal disorders
|
371.9
|
Unspecified corneal disorder
|
372.00–372.06
|
Acute conjunctivitis
|
372.10–372.15
|
Chronic conjunctivitis
|
372.20–372.22
|
Blepharoconjunctivitis
|
372.30–372.31
|
Other and unspecified conjunctivitis
|
372.33–372.34
|
Conjunctivitis in mucocutaneous disease
|
372.39
|
Other conjunctivitis
|
372.40–372.45
|
Pterygium
|
372.50–372.56
|
Conjunctival degenerations and deposits
|
372.61–372.64
|
Conjunctival scars
|
372.71–372.75
|
Conjunctival vascular disorders and cysts
|
372.81
|
Conjunctivochalasis
|
372.89
|
Other disorders of conjunctiva
|
372.9
|
Unspecified disorder of conjunctiva
|
373.00–373.02
|
Blepharitis
|
373.11–373.13
|
Hordeolum and other deep inflammation of the eyelid
|
373.2
|
Chalazion
|
373.31–373.34
|
Noninfectious dermatoses of eyelid
|
373.4–373.6
|
Inflammation of eyelids
|
373.8–373.9
|
Other inflammations of eyelids
|
374.00–374.05
|
Entropion and trichiasis of eyelid
|
374.10–374.14
|
Ectropion
|
374.20–374.23
|
Lagophthalmos
|
374.30–374.32
|
Ptosis of eyelid
|
374.34
|
Blepharochalasis
|
374.41
|
Lid retraction or lag
|
374.43–374.46
|
Other disorders affecting eyelid function
|
374.50–374.56
|
Degenerative disorders of eyelid and periocular area
|
374.81–374.87
|
Other disorders of eyelid
|
374.89
|
Other disorders of eyelid
|
374.9
|
Unspecified disorder of eyelid
|
375.00–375.03
|
Dacryoadenitis
|
375.11–375.16
|
Other disorders of lacrimal gland
|
375.20–375.22
|
Epiphora
|
375.30–375.33
|
Acute and unspecified inflammation of lacrimal passages
|
375.41–375.43
|
Chronic inflammation of lacrimal passages
|
375.51–375.54
|
Stenosis and insufficiency of lacrimal passages
|
375.56–375.57
|
Stenosis and insufficiency of lacrimal passages
|
375.61
|
Lacrimal fistula
|
375.69
|
Other changes of lacrimal passages
|
375.81
|
Granuloma of lacrimal passages
|
375.89
|
Other disorders of lacrimal system
|
375.9
|
Unspecified disorder of lacrimal system
|
376.00–376.04
|
Acute inflammation of orbit
|
376.10–376.13
|
Chronic inflammatory disorders orbit
|
376.21–376.22
|
Endocrine exophthalmos
|
376.30–376.36
|
Other exophthalmic conditions
|
376.40–376.47
|
Deformity of orbit
|
376.50–376.52
|
Enophthalmos
|
376.6
|
Retained (old) foreign body following penetrating wound of orbit
|
376.81–376.82
|
Orbital disorders
|
376.89
|
Other orbital disorders
|
376.9
|
Unspecified disorder of orbit
|
377.00–377.04
|
Papilledema
|
377.10–377.16
|
Optic atrophy
|
377.30–377.34
|
Optic neuritis
|
377.39
|
Other optic neuritis
|
377.41–377.43
|
Other disorders of optic nerve
|
377.49
|
Other disorders of optic nerve
|
377.51–377.54
|
Disorders of optic chiasm
|
377.61–377.63
|
Disorders of other visual pathways
|
377.71–377.73
|
Disorders of visual cortex
|
377.75
|
Cortical blindness
|
377.9
|
Unspecified disorder of optic nerve and visual pathways
|
378.00–378.08
|
Esotropia
|
378.10–378.18
|
Exotropia
|
378.20–378.24
|
Intermittent heterotropia
|
378.30–378.35
|
Other and unspecified heterotropia
|
378.40–378.45
|
Heterophoria
|
378.50–378.56
|
Paralytic strabismus
|
378.60–378.63
|
Mechanical strabismus
|
378.71–378.73
|
Other specified strabismus
|
378.81–378.87
|
Other dissociated binocular eye movements
|
378.9
|
Unspecified disorder of eye movements
|
379.00–379.07
|
Scleritis and episcleritis
|
379.09
|
Other scleritis
|
379.11–379.16
|
Other disorders of sclera
|
379.19
|
Other scleral disorders
|
379.21–379.26
|
Disorders of vitreous body
|
379.29
|
Other disorders of vitreous
|
379.31–379.34
|
Aphakia and other disorders of lens
|
379.39
|
Other disorders of lens
|
379.40–379.43
|
Anomalies of pupillary function
|
379.45–379.46
|
Anomalies of pupillary function
|
379.50–379.59
|
Nystagmus and other irregular eye movements
|
379.60–379.63 | Inflam postproc bleb |
379.8
|
Other specified disorders of eye and adnexa
|
379.90–379.93
|
Other disorder of eye and adnexa
|
379.99
|
Other ill-defined disorders of eye
|
446.5
|
Giant cell arteritis
|
648.00–648.04
|
Diabetes mellitus of mother complicating pregnancy childbirth or the puerperium unspecified as to episode of care – postpartum diabetes mellitus
|
694.61
|
Benign mucous membrane pemphigoid with ocular involvement
|
695.10-695.15
|
Erythema multiforme, unspecified
|
695.19
|
Other erythema multiforme
|
695.3
|
Rosacea
|
710.0
|
Systemic lupus erythematosus
|
710.2
|
Sicca syndrome
|
743.00
|
Clinical anophthalmos unspecified
|
743.03
|
Cystic eyeball congenital
|
743.06
|
Cryptophthalmos
|
743.10–743.12
|
Microphthalmos
|
743.20–743.22
|
Buphthalmos
|
743.30–743.37
|
Congenital cataract and lens anomalies
|
743.39
|
Other congenital cataract and lens anomalies
|
743.41–743.49
|
Coloboma and other anomalies of anterior segment
|
743.51–743.59
|
Congenital anomalies of posterior segment
|
743.61–743.66
|
Congenital anomalies of eyelids, lacrimal system and orbit
|
743.69
|
Other congenital anomalies of eyelids lacrimal system and orbit
|
743.8–743.9
|
Other congenital anomalies of eye
|
781.93
|
Ocular torticollis
|
784.0
|
Headache
|
870.0–870.4
|
Laceration of skin of eyelid and periocular area
|
870.8–870.9
|
Other specified open wounds of ocular adnexa
|
871.0–871.7
|
Open wound of eyeball
|
871.9
|
Unspecified open wound of eyeball
|
909.5
|
Late effect of adverse effect of drug medicinal or biological substance
|
918.0–918.2
|
Superficial injury of eye and adnexa
|
918.9
|
Other and unspecified superficial injuries of eye
|
921.0–921.3
|
Contusion of eye and adnexa
|
921.9
|
Unspecified contusion of eye
|
925.1
|
Crushing injury of face and scalp
|
930.0–930.2
|
Foreign body on external eye
|
930.8–930.9
|
Foreign body on external eye
|
940.0–940.5
|
Burn confined to eye and adnexa
|
940.9
|
Unspecified burn of eye and adnexa
|
941.02
|
Burn of unspecified degree of eye (with other parts of face head and neck)
|
941.12
|
Erythema due to burn (first degree) of eye (with other parts face head and neck)
|
941.22
|
Blisters with epidermal loss due to burn (second degree) of eye (with other parts of face head and neck)
|
941.32
|
Full-thickness skin loss due to burn (third degree nos) of eye (with other parts of face head and neck)
|
941.42
|
Deep necrosis of underlying tissues due to burn (deep third degree) of eye (with other parts of face head and neck) without loss of body part
|
941.52
|
Deep necrosis of underlying tissues due to burn (deep third degree) of eye (with other parts of face head and neck) with loss of a body part
|
950.0–950.3
|
Optic nerve injury – injury to visual cortex
|
950.9
|
Injury to unspecified optic nerve and pathways
|
951.0–951.4
|
Injury to oculomotor nerve – injury to facial nerve
|
976.5
|
Poisoning by eye anti-infectives and other eye drugs
|
996.51
|
Mechanical complication of prosthetic corneal graft
|
996.53
|
Mechanical complication of prosthetic ocular lens prosthesis
|
996.59
|
Mechanical complication of other implant and internal device not elsewhere classified
|
996.69
|
Infection and inflammatory reaction due to other internal prosthetic device implant and graft
|
996.70
|
Other complications due to unspecified device implant and graft
|
997.99
|
Complications affecting other specified body systems not elsewhere classified
|
998.31–998.32
|
Disruption of operation wound
|
998.51
|
Infected postoperative seroma
|
998.59
|
Other postoperative infection
|
998.6
|
Persistent postoperative fistula not elsewhere classified
|
998.82
|
Cataract fragments in eye following cataract surgery
|
998.89
|
Other specified complications of procedures not elsewhere classified
|
998.9
|
Unspecified complication of procedure not elsewhere classified
|
V41.0
|
Problems with sight
|
V41.1
|
Other eye problems
|
V42.5
|
Cornea replaced by transplant
|
V43.0
|
Eye globe replaced by other means
|
V43.1
|
Lens replaced by other means
|
V45.61
|
Cataract extraction status
|
V45.69
|
Other states following surgery of eye and adnexa
|
V45.78
|
Acquired absence of organ eye
|
V52.2
|
Fitting and adjustment of artificial eye
|
V57.4
|
Care involving orthoptic training
|
V58.62
|
Long-term (current) use of antibiotics
|
V58.65
|
Long-term (current) use of steroids
|
V58.69
|
Long-term (current) use of other medications
|
V59.5
|
Cornea donors
|
V67.51
|
Follow-up examination following completed treatment with high-risk medication not elsewhere classified
|
V71.1
|
Observation for suspected malignant neoplasm
|